PROTHROMBIN TIME (PT) AND INR

The Prothrombin Time (PT) and International Normalized Ratio (INR) Test is a commonly performed coagulation test used to evaluate how long it takes for blood to clot. It helps assess the function of the extrinsic and common coagulation pathways and plays a crucial role in diagnosing bleeding disorders, monitoring anticoagulant therapy, and evaluating liver function.

Prothrombin Time (PT) measures the time, in seconds, required for blood plasma to form a clot after the addition of specific reagents. Because PT results can vary between laboratories, the International Normalized Ratio (INR) was developed to standardize results and allow accurate comparison across different testing centers.

The PT/INR test is widely used to monitor patients taking warfarin (Coumadin®) and other vitamin K antagonist medications. Maintaining INR within a prescribed therapeutic range helps reduce the risk of excessive bleeding or abnormal clot formation.

Benefits of the Test

• Evaluates blood clotting ability
• Monitors warfarin therapy effectiveness
• Helps diagnose coagulation disorders
• Assesses liver-related clotting abnormalities
• Detects vitamin K deficiency-related clotting issues
• Supports preoperative coagulation assessment

Why Doctors Recommend This Test

Doctors may recommend PT and INR testing for:

• Monitoring warfarin treatment
• Unexplained bleeding or bruising
• Suspected clotting disorders
• Liver disease evaluation
• Vitamin K deficiency assessment
• Pre-surgical screening
• Deep Vein Thrombosis (DVT) management
• Pulmonary Embolism (PE) monitoring

The test helps ensure appropriate blood clotting function and safe anticoagulant therapy management.

Preparation Before Test

The test requires:

• Peripheral venous blood sample (citrated plasma)

Preparation generally includes:

• Fasting is usually not required
• Inform your physician about all medications and supplements
• Continue prescribed anticoagulants unless instructed otherwise
• Follow laboratory instructions for sample collection

Certain medications, herbal supplements, and dietary vitamin K intake may influence results.

Normal Reporting Time

Results are generally available on the same day or within 24 hours, depending on laboratory workflow.

Who Should Take This Test?

• Patients receiving warfarin therapy
• Individuals with unexplained bleeding
• Patients with liver disease
• Individuals undergoing surgery
• Patients with suspected coagulation disorders
• Individuals requiring thrombosis management

The PT/INR test is one of the most frequently ordered coagulation investigations worldwide.

Clinical Significance

Prolonged PT/INR may be associated with:

• Warfarin Therapy
• Liver Disease
• Vitamin K Deficiency
• Disseminated Intravascular Coagulation (DIC)
• Coagulation Factor Deficiencies
• Severe Infections
• Malabsorption Disorders

Shortened PT is less common but may occasionally be associated with increased clotting tendency.

For patients on anticoagulant therapy, maintaining INR within the physician-recommended therapeutic range is essential for effective treatment and safety.

Important Note

PT and INR results should always be interpreted together with clinical history, medication use, liver function tests, and other coagulation studies. Patients taking anticoagulants should never adjust medication doses without medical supervision.